The science of psychedelic therapy makes a breakthrough
Scientific studies of psychedelic therapies may enter a new, broader phase with increased interest and funding from federal governments. Why is this important: MDMA, psilocybin, and LSD – combined with psychotherapy – have shown promise for treating a range of addiction and mental health issues, including treatment-resistant depression and PTSD.Read More →